# Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer

> **NCT05285579** · — · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 100 (estimated)

## Conditions studied

- Renal Cell Carcinoma
- Renal Cancer
- Renal Cancer Metastatic

## Interventions

- **BIOLOGICAL:** Blood collection
- **OTHER:** Tumour samples

## Key facts

- **NCT ID:** NCT05285579
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-05
- **Primary completion:** 2025-08
- **Final completion:** 2025-08
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-04-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05285579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05285579, "Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05285579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*